Today’s Solutions: April 21, 2024

Big banks have traditionally been supporters of the fossil fuel industry and even after the signing of the Paris Agreement in 2015, large financial institutions continued to pour $3.6 trillion into fossil fuel projects. It seems like 2021 might finally be the year that large banks get on board with a greener future as green bonds and loans from the global banking sector have exceeded fossil fuel financing for the first time. 

A Bloomberg study concludes that big banks have contributed $203 billion in bonds and loans to renewable projects and other climate-friendly ventures this year and only $189 billion to businesses focused on hydrocarbons.

The biggest financial actor in green energy funding is JPMorgan Chase, followed by Citigroup, Bank of America, and Wells Fargo. Bloomberg notes that the world will need an estimated $3 trillion in annual renewables investments to limit warming to 2 degrees Celsius by 2050, meaning investments will have to increase fivefold in the next 30 years. 

Although we have not hit our ultimate goals in terms of renewables funding and fossil fuel divestment, this data is a promising indicator that even the staunchest supporters of fossil fuel are beginning to accept the transition to green energy. 

Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More